European Medical Journal

AI and Big Data in Surgery: Emerging Evidence from the Frontline

AI is rapidly reshaping the landscape of surgical oncology. However, its true potential lies not in isolated tools, but rather ...
Pakistan Today

‘Ready For Long War’: Iran denies seeking ceasefire as missile attacks and regional tensions escalate

Iran's Foreign Minister Abbas Araghchi firmly denies any request for a ceasefire, asserting the nation's readiness for a ...
The Manila Times

Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Greenwich LifeSciences Provides Update on Upcoming AACR Meeting

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
Scientific American

The curious math that explains why fashion trends always come back around

Fashion followers know that trends tend to reappear on a 20-year cycle, and a new analysis of more than 150 years’ worth of ...

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
The Manila Times

Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Greenwich LifeSciences, Inc.: Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
European Medical Journal

Predictors of Medication Adherence and Quality of Life Among Patients with Epilepsy in Nigeria

Epilepsy is one of the common disorders known to man, with early accounts of the disorder traced back to antiquity.1 It was ...

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01

Detailed price information for Greenwich Lifesciences Inc (GLSI-Q) from The Globe and Mail including charting and trades.
Scientific Research Publishing

Ketogenic Therapies and ADHD in Children: A Narrative Review of Possible Mechanisms, Indirect Evidence, and Research Gaps ()

Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children and adults. Recently, there has been growing interest in the potential role of diet in the ...